Literature DB >> 18796314

Repeated stress in combination with pyridostigmine Part II: changes in cerebral gene expression.

Laure Barbier1, Michel Diserbo, Ioannis Lamproglou, Christine Amourette, André Peinnequin, William Fauquette.   

Abstract

Organophosphates (OP) represent a potential threat in terrorism or during military conflicts. Due to its faculty to protect cholinesterase (ChE) activity against irreversible inactivation by OP, pyridostigmine bromide (PB) was used as a prophylaxis treatment during the first Persian Gulf War. To explain dysfunctions reported by Gulf War Veterans (GWV), it was suggested a potentiation of the operational stress effects by PB given to soldiers. Our companion paper (see part 1 in the same journal issue) describes that PB treatment administered in repeated stress conditions results in long-term perturbations of learning and social behaviour. The present paper examines, in adult male Wistar rats, consequences of the association of repeated stress and PB treatment on gene expression in hypothalamus and hippocampus. PB treatment (1.5 mg/kg/day) was orally administered 30 min before each stress session to inhibit 40% of blood ChE as recommended by NATO. 10 days of stress alone induce a decrease in hypothalamic Il-1alpha expression. Treatment with PB alone increases mineralocorticoid receptor expression in hypothalamus which means that PB may thus modify stress perception by animals. Stressed-PB animals showed increase in hippocampal expression of BDNF, TrkB and CamKIIalpha, three genes implicated in memory development. As a supplement to previous studies showing behavioural and biochemical effects of the association of stress with PB, our data reveal that behavioural effects of this association may be linked with genomic changes in hippocampus. Mechanisms underlying these modifications and their link with memory disturbances reported by GWV remain to be further determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796314     DOI: 10.1016/j.bbr.2008.08.032

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  13 in total

1.  Stress does not increase blood-brain barrier permeability in mice.

Authors:  Martin Roszkowski; Johannes Bohacek
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-04       Impact factor: 6.200

2.  Towards a Treatment for Gulf War Illness: A Consensus Docking Approach.

Authors:  Rajeev Jaundoo; Jonathan Bohmann; Gloria E Gutierrez; Nancy Klimas; Gordon Broderick; Travis J A Craddock
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

3.  Pyridostigmine bromide and stress interact to impact immune function, cholinergic neurochemistry and behavior in a rat model of Gulf War Illness.

Authors:  V A Macht; J L Woodruff; E S Maissy; C A Grillo; M A Wilson; J R Fadel; L P Reagan
Journal:  Brain Behav Immun       Date:  2019-04-03       Impact factor: 7.217

Review 4.  Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies.

Authors:  Brandon Dickey; Leelavathi N Madhu; Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

5.  A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome.

Authors:  Anne Liese Smylie; Gordon Broderick; Henrique Fernandes; Shirin Razdan; Zachary Barnes; Fanny Collado; Connie Sol; Mary Ann Fletcher; Nancy Klimas
Journal:  BMC Immunol       Date:  2013-06-25       Impact factor: 3.615

6.  Achieving Remission in Gulf War Illness: A Simulation-Based Approach to Treatment Design.

Authors:  Travis J A Craddock; Ryan R Del Rosario; Mark Rice; Joel P Zysman; Mary Ann Fletcher; Nancy G Klimas; Gordon Broderick
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

7.  Corticosterone primes the neuroinflammatory response to DFP in mice: potential animal model of Gulf War Illness.

Authors:  James P O'Callaghan; Kimberly A Kelly; Alicia R Locker; Diane B Miller; Steve M Lasley
Journal:  J Neurochem       Date:  2015-03-24       Impact factor: 5.372

8.  Phospholipid profiling of plasma from GW veterans and rodent models to identify potential biomarkers of Gulf War Illness.

Authors:  Tanja Emmerich; Zuchra Zakirova; Nancy Klimas; Kimberly Sullivan; Ashok K Shetty; James E Evans; Ghania Ait-Ghezala; Gary S Laco; Bharathi Hattiangady; Geetha A Shetty; Michael Mullan; Gogce Crynen; Laila Abdullah; Fiona Crawford
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

9.  Using gene expression signatures to identify novel treatment strategies in gulf war illness.

Authors:  Travis J A Craddock; Jeanna M Harvey; Lubov Nathanson; Zachary M Barnes; Nancy G Klimas; Mary Ann Fletcher; Gordon Broderick
Journal:  BMC Med Genomics       Date:  2015-07-09       Impact factor: 3.063

10.  A Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure.

Authors:  Zuchra Zakirova; Gogce Crynen; Samira Hassan; Laila Abdullah; Lauren Horne; Venkatarajan Mathura; Fiona Crawford; Ghania Ait-Ghezala
Journal:  Front Integr Neurosci       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.